Glucose-sensitive nanoparticle for cancer diagnosis and therapy
US-2015374828-A1 · Dec 31, 2015 · US
US9872926B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9872926-B2 |
| Application number | US-201615297862-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 19, 2016 |
| Priority date | Apr 5, 2012 |
| Publication date | Jan 23, 2018 |
| Grant date | Jan 23, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to pH-tunable, highly activatable multicolored fluorescent nanoplatforms and methods of using the nanoplatforms in a variety of applications including, but not limited to, investigating fundamental cell physiological processes such as pH regulation in endocytic vesicles, endosome/lysosome maturation, and effect of pH on receptor cycling and trafficking of subcellular organelles.
Opening claim text (preview).
The invention claimed is: 1. A method of monitoring vesicular trafficking comprising: (i) contacting a cell with a composition comprising at least a first and second micelle population, wherein each micelle population comprises a block copolymer and a fluorescent dye, and further wherein the first micelle population has a first pH transition point and a first fluorescent emission spectra, the second micelle population has a second pH transition point and a second fluorescent emission spectra, and further wherein the first and second pH transition points are not identical and the first and second fluorescent dyes are not identical, under conditions whereby the cell takes up the composition by endocytosis; wherein the first micelle population and the second micelle population are each independently a copolymer comprising a) a hydrophilic polymer segment according to formula: b) a hydrophobic polymer segment according to formula A 1 ; and c) a polymer segment according to formula A 2 ; or a pharmaceutically acceptable salt thereof; and stereoisomers, isotopic variants and tautomers thereof; wherein each A 1 and A 2 is independently selected from each R 1a is independently H, substituted or unsubstituted alkyl, or each R 2a , R 2b , R 3a , R 3b , R 4a , R 4b , R 4c , R 4d , and R 5 is independently H or substituted or unsubstituted alkyl; each R 6a , and R 6b is independently substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; or R 6a , and R 6b taken together with the N atom they are attached to form heterocycle; R 7 is a moiety comprising a dye selected from the group consisting of rhodamine, BODIPY, coumarin, and cyanine; the subscript n is an integer between 10 to 200; and wherein the copolymer is a random copolymer; (ii) detecting in the cell a first and/or second fluorescent signal corresponding to the first, and/or second fluorescent emission spectra, wherein the detection of first and/or second fluorescent signals indicates that each micelle population comprising a corresponding fluorescent dye has reached its pH transition point and that the micelle population has disassociated; and (iii) determining what compartment the endocytosed micelle population was in when it dissociated based on the pH transition point of the micelle. 2. The method of claim 1 , wherein the A 1 has the formula: 3. The method of claim 1 , wherein R 7 is a moiety comprising a cyanine dye. 4. The method of claim 1 , wherein the A 2 has the formula: 5. A method of monitoring vesicular trafficking comprising: (i) contacting a cell with a composition comprising at least a first, second, and third micelle population, wherein each micelle population comprises a block copolymer and a fluorescent dye, and further wherein the first micelle population has a pH transition point between about pH 6.3-7.4 and a first fluorescent emission spectra, the second micelle population has a pH transition point between about pH 5.9-6.2 and a second fluorescent emission spectra, and the third micelle population has a pH transition point between about pH 5.0-5.8 and a third fluorescent emission spectra, under conditions whereby the cell takes up the composition by endocytosis; wherein the first micelle population, the second micelle population, and the third micelle population are each independently a copolymer comprising a) a hydrophilic polymer segment according to formula: b) a hydrophobic polymer segment according to formula A 1 ; and c) a polymer segment according to formula A 2 ; or a pharmaceutically acceptable salt thereof; and stereoisomers, isotopic variants and tautomers thereof; wherein each A 1 and A 2 is independently selected from each R 1a is independently H, substituted or unsubstituted alkyl, or each R 2a , R 2b , R 3a , R 3b , R 4a , R 4b , R 4c , R 4d , and R 5 is independently H or substituted or unsubstituted alkyl; each R 6a , and R 6b is independently substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; or R 6a , and R 6b taken together with the N atom they are attached to form heterocycle; R 7 is a moiety comprising a dye selected from the group consisting of rhodamine, BODIPY, coumarin, and cyanine; the subscript n is an integer between 10 to 200; and wherein the copolymer is a random copolymer; (ii) detecting in the cell a first, second, and third fluorescent signal corresponding to the first, second, and third fluorescent emission spectra, wherein the detection of first, second, and third fluorescent signals indicates that each micelle population comprising a corresponding fluorescent dye has reached its pH transition point and that the micelle population has disassociated; and (iii) determining that a vesicle is an early endosome when the first fluorescent signal is detected, determining that a vesicle is a late endosome/lysosome when the second fluorescent signal is detected, and determining that a vesicle is a lysosome when the third fluorescent signal is detected. 6. The method of claim 5 , wherein the A 1 has the formula: 7. The method of claim 5 , wherein R 7 is a moiety comprising a cyanine dye. 8. The method of claim 5 , wherein the A 2 has the formula: 9. A method of monitoring endosome pH comprising: (i) contacting an endosome with a composition comprising at least a first and second micelle population, wherein each micelle population comprises a block copolymer and a fluorescent dye, and further wherein the first micelle population has a pH transition point between about pH 5.7-6.3 and a first fluorescent emission spectra, the second micelle population has a pH transition point between about pH 5.7-6.3 and a second fluorescent emission spectra, wherein the first and second micelle populations have different pH transition points and different fluorescent emission spectra, under conditions whereby the endosome takes up the composition; wherein the first micelle population and the second micelle population are each independently a copolymer comprising a) a hydrophilic polymer segment according to formula: b) a hydrophobic polymer segment according to formula A 1 ; and
Methine dyes, e.g. cyanine dyes · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
micelle, e.g. phospholipidic micelle and polymeric micelle · CPC title
Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title
for testing non-proliferative effects · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.